Human genomics technologies in clinical studies – the research landscape: report on the 1990–2024 period

Published on 14 December, this WHO technical document maps global trends in registered clinical studies using human genomic technologies from 1990 to 2024, including patterns of inclusion and equity.

This WHO snapshot provides a global overview of clinical studies involving human genomic technologies registered between 1990 and 2024. It summarises how research activity has evolved over time and examines patterns in growth, disease focus, geographical distribution and population inclusion, with specific attention to equity of participation. The report is intended to inform stakeholders about the current landscape of genomics in clinical research and where gaps or imbalances may remain.

Acces this publication
Scientific paper

Year of publication

2025

Source

World Health Organization (WHO) (Technical document; WHO Team: Research for Health (RFH))

Author

WHO Team: Research for Health (RFH)

You might also be interested in

Genetic Mapping

New clinical trial guidance supports research beyond the hospital

New international guidance supports decentralised clinical trials, pragmatic designs and the use of real-world data.
Ana Rath at ERDERA GAM 2025

“By handling data in a structured and responsible way, we can build a shared European ecosystem”

Ana Rath, Data Services Co-Lead in ERDERA, explains how the consortium is helping researchers and data holders make rare disease data more findable, interoperable and reusable while protecting privacy and keeping data holders in control.
Journée nationale FrBioNet

ERDERA connects rare disease research and biobanking at FrBioNet’s first national event

ERDERA contributed to the first Journée nationale FrBioNet, bringing a European rare disease perspective to discussions with the French biobanking community.
ERDERA - World Orphan Drug Congress - JVDPhotography-40

Can AI deliver for rare diseases? ERDERA brings the debate to WODC Europe

ERDERA will return to the World Orphan Drug Congress Europe with a booth and an interactive pre-conference workshop examining where artificial intelligence can support rare disease research and therapeutic development, and where human expertise remains essential.

ERDERA Search